PO-0706: Pelvic IMRT with hypofractionated SIB to prostate for high-risk prostate cancer: a phase II study

A Phase II Study of Stereotactic Body Radiation Therapy for Low-Intermediate-High-Risk Prostate Cancer Using Helical Tomotherapy: Dose-Volumetric Parameters Predicting Early Toxicity

Frontiers in Oncology ◽

10.3389/fonc.2014.00336 ◽

2014 ◽

Vol 4 ◽

Cited By ~ 11

Author(s):

Victor A. Macias ◽

Manuel L. Blanco ◽

Inmaculada Barrera ◽

Rafael Garcia

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase Ii ◽

Stereotactic Body Radiation Therapy ◽

Helical Tomotherapy ◽

Phase Ii Study ◽

Risk Prostate Cancer ◽

Early Toxicity

Phase II Study of Vinorelbine and Estramustine in Combination With Conformational Radiotherapy for Patients With High-Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.03.024 ◽

2010 ◽

Vol 76 (4) ◽

pp. 1085-1091 ◽

Cited By ~ 5

Author(s):

Joan Carles ◽

Miguel Nogue ◽

Josep M. Sole ◽

Palmira Foro ◽

Montserrat Domenech ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase Ii ◽

Phase Ii Study ◽

Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: Preliminary results of a prospective phase II study

International Journal of Hyperthermia ◽

10.1080/02656730701553260 ◽

2007 ◽

Vol 23 (5) ◽

pp. 451-456 ◽

Cited By ~ 25

Author(s):

S. Maluta ◽

S. Dall’oglio ◽

M. Romano ◽

N. Marciai ◽

F. Pioli ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Conformal Radiotherapy ◽

Local Hyperthermia ◽

Risk Prostate Cancer ◽

Prospective Phase

A pilot multicenter phase II study of adjuvant docetaxel (D) for high risk prostate cancer (PC) patients (pts) after radical prostatectomy (RP): Preliminary data

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4565 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4565-4565 ◽

Cited By ~ 3

Author(s):

E. Rosenbaum ◽

A. Kibel ◽

B. Roth ◽

G. Wilding ◽

R. Dreicer ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Phase Ii ◽

Preliminary Data ◽

Phase Ii Study ◽

Multicenter Phase ◽

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study

Radiation Oncology ◽

10.1186/s13014-020-01577-5 ◽

2020 ◽

Vol 15 (1) ◽

Author(s):

Almudena Zapatero ◽

Antonio Gómez-Caamaño ◽

María Ángeles Cabeza Rodriguez ◽

Laura Muinelo-Romay ◽

Carmen Martin de Vidales ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Phase Ii ◽

Phase Ii Study ◽

Risk Prostate Cancer ◽

Prospective Phase

Neoadjuvant apalutamide (arn-509) and radical prostatectomy in treatment of intermediate to high risk prostate cancer (NEAR) – initial results of a phase II trial

European Urology Supplements ◽

10.1016/s1569-9056(19)31008-5 ◽

2019 ◽

Vol 18 (1) ◽

pp. e1394

Author(s):

E.J. Aslim ◽

X. Yang ◽

N-T. Ngo ◽

L.Y. Khor ◽

K. Chen ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Phase Ii ◽

Phase Ii Trial ◽

Risk Prostate Cancer ◽

Initial Results

Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer

Advances in Radiation Oncology ◽

10.1016/j.adro.2019.11.007 ◽

2020 ◽

Vol 5 (3) ◽

pp. 396-403 ◽

Cited By ~ 1

Author(s):

Christian Ekanger ◽

Svein Inge Helle ◽

Daniel Heinrich ◽

Dag Clement Johannessen ◽

Ása Karlsdóttir ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase Ii Study ◽

Intensity Modulated Radiation Therapy ◽

Image Guided ◽

Intensity Modulated ◽

Risk Prostate Cancer ◽

Integrated Boost

21 The Eldorado Study: A Phase II Randomised Study of Chemo-Radiation and Long-Term Androgen Deprivation in Patients with High-Risk Prostate Cancer. A Re-Analysis of the Primary Endpoint

Radiotherapy and Oncology ◽

10.1016/s0167-8140(19)33271-2 ◽

2019 ◽

Vol 139 ◽

pp. S12

Author(s):

Derek Wilke ◽

Lori Wood ◽

Helmut Hollenhorst ◽

Robert Rutledge ◽

David Bowes ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase Ii ◽

Primary Endpoint ◽

Androgen Deprivation ◽

Randomised Study ◽

Hypofractionated Carbon Ion Radiotherapy for D’Amico High-risk Prostate Cancer; a Subset Analysis of a Phase II Clinical Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.458 ◽

2020 ◽

Vol 108 (3) ◽

pp. e874-e875

Author(s):

S. Toyama ◽

Y. Shioyama ◽

H. Suefuji ◽

M. Shinoto ◽

H. Hirata ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

High Risk ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Carbon Ion Radiotherapy ◽

Carbon Ion ◽

Subset Analysis ◽

Re: Intense Androgen-Deprivation Therapy with Abiraterone Acetate plus Leuprolide Acetate in Patients with Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study

The Journal of Urology ◽

10.1016/j.juro.2015.03.046 ◽

2015 ◽

Vol 193 (6) ◽

pp. 1983-1983

Author(s):

Samir S. Taneja

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Androgen Deprivation Therapy ◽

Phase Ii ◽

Abiraterone Acetate ◽

Androgen Deprivation ◽

Leuprolide Acetate ◽

Randomized Phase Ii ◽